Yahoo
NYSE USD

American Healthcare REIT, Inc. (AHR)

53.52 +0.58 (+1.10%)
At close: October 30 at 4:00:02 PM EDT
53.52 0.00 (0.00%)
After hours: October 30 at 4:00:50 PM EDT
Trade AHR on Coinbase
Chart Range Bar
Loading chart for AHR
  • Previous Close 52.94
  • Open 53.47
  • Bid 53.54 x 30000
  • Ask 53.51 x 20000
  • Day's Range 52.98 - 54.20
  • 52 Week Range 44.61 - 58.70
  • Volume 2,911,385
  • Avg. Volume 3,107,423
  • Market Cap (intraday) 11.667B
  • Beta (5Y Monthly) 0.80
  • PE Ratio (TTM) 79.88
  • EPS (TTM) 0.67
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield 1.00 (1.89%)
  • 1y Target Est 63.69
  • Motley Fool Rating Bullish

American Healthcare REIT, Inc., a Maryland-based self-managed REIT, owns and operates a diversified portfolio of clinical healthcare real estate across the U.S., U.K., and the Isle of Man. Its focus includes senior housing, skilled nursing facilities (SNFs), outpatient medical (OM) buildings, and other healthcare-related properties. The company utilizes a fully integrated management platform and operates senior housing under the RIDEA structure. In addition to owning and operating properties, it has originated and acquired secured loans and may pursue other real estate-related investments opportunistically. The REIT seeks income-generating assets and selectively develops healthcare properties. It has elected to be taxed as a REIT under the U.S. Internal Revenue Code and intends to maintain compliance with REIT requirements. American Healthcare REIT, Inc. is based in Irvine, United States.

www.americanhealthcarereit.com

121

Full Time Employees

December 31

Fiscal Year Ends

Real Estate

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AHR
15.44%
S&P 500 (^GSPC)
10.73%

1-Year Return

AHR
20.56%
S&P 500 (^GSPC)
11.11%

3-Year Return

AHR
316.50%
S&P 500 (^GSPC)
81.91%

5-Year Return

AHR
316.50%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 674.25M
Earnings 30.61M
Profit Margin 4.54%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
200M
400M
600M
2.0%
4.0%
6.0%
8.0%

Analyst Insights

View More

Analyst Price Targets

55.00
63.69 Average
53.52 Current
74.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/13/2026
Analyst UBS
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 63 -> 62

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.83%

  • Return on Assets (ttm)

    2.10%

  • Return on Equity (ttm)

    3.95%

  • Revenue (ttm)

    2.5B

  • Net Income Avi to Common (ttm)

    121.02M

  • Diluted EPS (ttm)

    0.67

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    157.85M

  • Total Debt/Equity (mrq)

    41.89%

  • Levered Free Cash Flow (ttm)

    396.68M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: